Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-Saharan Africa

Journal of Virology

Volumn 89, Issue 4, 2015, Pages 2104-2111

  Mackelprang, Romel D ^a   Carrington, Mary ^b,c   Thomas, Katherine K ^a   Hughes, James P ^a,d   Baeten, Jared M ^a   Wald, Anna ^a,d   Farquhar, Carey ^a   Fife, Kenneth ^e   Campbell, Mary S ^a   Kapiga, Saida ^f,g   Gao, Xiaojiang ^b   Mullins, James I ^a   Lingappa, Jairam R ^a,h  

^a UNIVERSITY OF WASHINGTON   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e INDIANA UNIVERSITY   (United States)

^f National Institute for Medical Research   (Tanzania)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; VIRUS RNA; HLA ANTIGEN;

ADAPTIVE IMMUNITY; AFRICA SOUTH OF THE SAHARA; AFRICAN; ALLELE; ARTICLE; BLOOD LEVEL; CIRCUMCISION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FACTORIAL ANALYSIS; FEMALE; GENETIC VARIABILITY; GENITAL HERPES; HLA CLASS I GENE; HUMAN; HUMAN GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; NONHUMAN; OBSERVATIONAL STUDY; PREDICTION; PROSPECTIVE STUDY; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; TLR2 GENE; TLR7 GENE; VAGINITIS; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS TRANSMISSION; BLOOD; DISEASE PREDISPOSITION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; TRANSMISSION; VIROLOGY;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

AFRICA SOUTH OF THE SAHARA; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; MALE; RNA, VIRAL; VIRAL LOAD;

EID: 84921640570     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01573-14     Document Type: Article

References (67)

1. Lavreys L, Baeten JM, Chohan V, McClelland RS, Hassan WM, Richardson BA, Mandaliya K, Ndinya-Achola JO, Overbaugh J. 2006. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis 42:1333-1339. http://dx.doi.org/10.1086/503258.
2. Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, Kingsley LA. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170. http://dx.doi.org/10.1126/science.272.5265.1167.
3. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH. 2000. Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1. N Engl J Med 342:921-929. http://dx.doi.org/10.1056/NEJM200003303421303.
4. Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C, Essex M, Mullins JI, Coombs RW, Rees H, Corey L, Wald A. 2010. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One 5:e12598. http://dx.doi.org/10.1371/journal.pone.0012598.
5. Lingappa JR, Thomas KK, Hughes JP, Baeten JM, Wald A, Farquhar C, Fife KH, Campbell MS, Kapiga S, Mullins JI. 2013. Partner characteristics predicting HIV-1 setpoint in sexually acquired HIV-1 among African seroconverters. AIDS Res Hum Retrovir 29:164-171. http://dx.doi.org/10.1089/aid.2012.0206.
6. Hollingsworth TD, Laeyendecker O, Shirreff G, Donnelly CA, Serwadda D, Wawer MJ, Kiwanuka N, Nalugoda F, Collinson-Streng A, Ssempijja V, Hanage WP, Quinn TC, Gray RH, Fraser C. 2010. HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda. PLoS Pathog 6:e1000876. http://dx.doi.org/10.1371/journal.ppat.1000876.
7. Hecht FM, Hartogensis W, Bragg L, Bacchetti P, Atchison R, Grant R, Barbour J, Deeks SG. 2010. HIV RNA level in early infection is predicted by viral load in the transmission source. AIDS 24:941-945. http://dx.doi.org/10.1097/QAD.0b013e328337b12e.
8. Alizon S, von Wyl V, Stadler T, Kouyos RD, Yerly S, Hirschel B, Böni J, Shah C, Klimkait T, Furrer H, Rauch A, Vernazza PL, Bernasconi E, Battegay M, Bürgisser P, Telenti A, Günthard HF, Bonhoeffer S, Boni J, Burgisser P, Gunthard HF. 2010. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog 6:e1001123. http://dx.doi.org/10.1371/journal.ppat.1001123.
9. Yue L, Prentice HA, Farmer P, Song W, He D, Lakhi S, Goepfert P, Gilmour J, Allen S, Tang JJ, Kaslow RA, Hunter E. 2013. Cumulative impact of host and viral factors on HIV-1 viral load control during early infection. J Virol 87:708-715. http://dx.doi.org/10.1128/JVI.02118-12.
10. Van der Kuyl AC, Jurriaans S, Pollakis G, Bakker M, Cornelissen M. 2010. HIV RNA levels in transmission sources only weakly predict plasma viral load in recipients. AIDS 24:1607-1608. http://dx.doi.org/10.1097/QAD.0b013e32833b318f.
11. Goulder PJ, Walker BD. 2012. HIV and HLA class I: an evolving relationship. Immunity 37:426-440. http://dx.doi.org/10.1016/j.immuni.2012.09.005.
12. Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, Seoighe C, Treurnicht F, de Rosa DA, Hide W, Karim SA, Gray CM, Williamson C. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog 4:e1000033. http://dx.doi.org/10.1371/journal.ppat.1000033.
13. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJR. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10:282-289. http://dx.doi.org/10.1038/nm992.
14. Crawford H, Lumm W, Leslie A, Schaefer M, Boeras D, Prado JG, Tang JJ, Farmer P, Ndung'u T, Lakhi S, Gilmour J, Goepfert P, Walker BD, Kaslow R, Mulenga J, Allen S, Goulder PJ, Hunter E. 2009. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J Exp Med 206:909-921. http://dx.doi.org/10.1084/jem.20081984.
15. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, Connors M. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 97:2709-2714. http://dx.doi.org/10.1073/pnas.050567397.
16. Goonetilleke N, Liu MKP, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, Weinhold KJ, Moore S, Letvin N, Haynes BF, Cohen MS, Hraber P, Bhattacharya T, Borrow P, Perelson AS, Hahn BH, Shaw GM, Korber BT, McMichael AJ. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206: 1253-1272. http://dx.doi.org/10.1084/jem.20090365.
17. Matthews PC, Prendergast A, Leslie A, Crawford H, Payne R, Rousseau C, Rolland M, Honeyborne I, Carlson J, Kadie C, Brander C, Bishop K, Mlotshwa N, Mullins JI, Coovadia H, Ndung'u T, Walker BD, Heckerman D, Goulder PJR. 2008. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol 82: 8548-8559. http://dx.doi.org/10.1128/JVI.00580-08.
18. Sobieszczyk ME, Lingappa JR, McElrath MJ. 2011. Host genetic polymorphisms associated with innate immune factors and HIV-1. Curr Opin HIV AIDS 6:427-434. http://dx.doi.org/10.1097/COH.0b013e3283497155.
19. Beignon A-S, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD, Bhardwaj N. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Investig 115:3265-3275. http://dx.doi.org/10.1172/JCI26032.
20. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529. http://dx.doi.org/10.1126/science.1093620.
21. Meier A, Alter G, Frahm N, Sidhu H, Li B, Bagchi A, Teigen N, Streeck H, Stellbrink H-J, Hellman J, van Lunzen J, Altfeld M. 2007. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 81:8180-8191. http://dx.doi.org/10.1128/JVI.00421-07.
22. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of singlestranded RNA. Science 303:1529-1531. http://dx.doi.org/10.1126/science.1093616.
23. Martinelli E, Cicala C, Van Ryk D, Goode DJ, Macleod K, Arthos J, Fauci AS. 2007. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-alpha secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci USA 104:3396-3401. http://dx.doi.org/10.1073/pnas.0611353104.
24. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo NR, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie JN, Farquhar C, John-Stewart GC, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen SA, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Stevens W, Campbell MS, Thomas KK, Coombs RW, Morrow R, Whittington WLH, McElrath MJ, Barnes L, Ridzon R, Corey L. 2010. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362:427-439. http://dx.doi.org/10.1056/NEJMoa0904849.
25. Lingappa JR, Petrovski S, Kahle E, Fellay J, Shianna KV, McElrath MJ, Thomas KK, Baeten JM, Celum C, Wald A, De Bruyn G, Mullins JI, Nakku-Joloba E, Farquhar C, Essex M, Donnell D, Kiarie JN, Haynes B, Goldstein DB. 2011. Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. PLoS One 6:e28632. http://dx.doi.org/10.1371/journal.pone.0028632.
26. Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR. 1995. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 35:91-97. http://dx.doi.org/10.1046/j.1537-2995.1995.35295125745.x.
27. Lavreys L, Baeten JM, Kreiss JK, Richardson BA, Chohan BH, Hassan W, Panteleeff DD, Mandaliya K, Ndinya-Achola JO, Overbaugh J. 2004. Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis 189:303-311. http://dx.doi.org/10.1086/380974.
28. Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, Raugi DN, Sorensen S, Stoddard JN, Zhao H, Deng W, Kahle E, Panteleeff D, Baeten JM, McCutchan FE, Albert J, Leitner T, Wald A, Corey L, Lingappa JR, Partners in Prevention HSV/HIV Transmission Study Team. 2011. Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One 6:e16986. http://dx.doi.org/10.1371/journal.pone.0016986.
29. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344:1668-1675. http://dx.doi.org/10.1056/NEJM200105313442203.
30. Mackelprang RD, Bigham AW, Celum C, de Bruyn G, Beima K, John-Stewart GC, Ronald A, Mugo NR, Reiner AP, Buckingham KJ, Bamshad MJ, Mullins JI, McElrath M, Lingappa JR. 2014. Toll-like receptor polymorphism associations with HIV-1 acquisition, viral setpoint and disease progression. J Infect Dis 209:1623-1627. http://dx.doi.org/10.1093/infdis/jit807.
31. R Development Core Team. 2008. R: a language and environment for statistical computing. Vienna, Austria. http://www.R-project.org.
32. Bochud P-Y, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD, Calandra T, Francioli P, Telenti A, Speck RF, Aderem A. 2007. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 21:441-446. http://dx.doi.org/10.1097/QAD.0b013e328012b8ac.
33. Pine SO, McElrath MJ, Bochud P-Y. 2009. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS 23:2387-2395. http://dx.doi.org/10.1097/QAD.0b013e328330b489.
34. Oh D-Y, Baumann K, Hamouda O, Eckert JK, Neumann K, Kücherer C, Bartmeyer B, Poggensee G, Oh N, Pruss A, Jessen H, Schumann RR. 2009. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 23:297-307. http://dx.doi.org/10.1097/QAD.0b013e32831fb540.
35. Oh D-Y, Taube S, Hamouda O, Kücherer C, Poggensee G, Jessen H, Eckert JK, Neumann K, Storek A, Pouliot M, Borgeat P, Oh N, Schreier E, Pruss A, Hattermann K, Schumann RR. 2008. A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis 198:701-709. http://dx.doi.org/10.1086/590431.
36. Papadopoulos AI, Ferwerda B, Antoniadou A, Sakka V, Galani L, Kavatha D, Panagopoulos P, Poulakou G, Kanellakopoulou K, van der Meer JWM, Giamarellos-Bourboulis EJ, Netea MG. 2010. Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection. Clin Infect Dis 51:242-247. http://dx.doi.org/10.1086/653607.
37. Ricci E, Malacrida S, Zanchetta M, Mosconi I, Montagna M, Giaquinto C, De Rossi A. 2010. Toll-like receptor 9 polymorphisms influence mother-tochild transmission of human immunodeficiency virus type 1. J Transl Med 8:49. http://dx.doi.org/10.1186/1479-5876-8-49.
38. Sironi M, Biasin M, Cagliani R, Forni D, De Luca M, Saulle I, Lo Caputo S, Mazzotta F, Macías J, Pineda JA, Caruz A, Clerici M. 2012. A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. J Immunol 188:818-823. http://dx.doi.org/10.4049/jimmunol.1102179.
39. Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, del Rodríguez MM, Salinas A, Pulido I, Sáez ME, Leal M. 2008. Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr 49:128-135. http://dx.doi.org/10.1097/QAI.0b013e318184fb41.
40. Prince HE, Schroff RW, Ayoub G, Han S, Gottlieb MS, Fahey JL. 1984. HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma. J Clin Immunol 4:242-245. http://dx.doi.org/10.1007/BF00914972.
41. Mann DL, Murray C, O'Donnell M, Blattner WA, Goedert JJ. 1990. HLA antigen frequencies in HIV-1-related Kaposi's sarcoma. J Acquir Immune Defic Syndr 3(Suppl 1):S51-S55.
42. Chen Y, Winchester R, Korber B, Gagliano J, Bryson Y, Hutto C, Martin N, McSherry G, Petru A, Wara D, Ammann A. 1997. Influence of HLA alleles on the rate of progression of vertically transmitted HIV infection in children: association of several HLA-DR13 alleles with longterm survivorship and the potential association of HLA-A*2301 with rapid progression to AIDS. Long-term survivor study. Hum Immunol 55:154-162.
43. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, Mann DL. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2:405-411. http://dx.doi.org/10.1038/nm0496-405.
44. Mackelprang RD, Carrington M, John-Stewart G, Lohman-Payne B, Richardson BA, Wamalwa D, Gao X, Majiwa M, Mbori-Ngacha D, Farquhar C. 2010. Maternal human leukocyte antigen A*2301 is associated with increased mother-to-child HIV-1 transmission. J Infect Dis 202: 1273-1277. http://dx.doi.org/10.1086/656318.
45. Tang JJ, Tang S, Lobashevsky E. 2002. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 76:8276-8284. http://dx.doi.org/10.1128/JVI.76.16.8276-8284.2002.
46. Tang JJ, Shao W, Yoo YJ, Brill I, Mulenga J, Allen S, Hunter E, Kaslow RA. 2008. Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples. J Immunol 181:2626-2635. http://dx.doi.org/10.4049/jimmunol.181.4.2626.
47. MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJ, Ball TB, Oyugi J, Njagi E, Gaur LK, Brunham RC, Wade J, Luscher MA, Krausa P, Rowland-Jones S, Ngugi E, Bwayo JJ, Plummer F. 2000. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 181:1581-1589. http://dx.doi.org/10.1086/315472.
48. Peterson TA, Kimani J, Wachihi C, Bielawny T, Mendoza L, Thavaneswaran S, Narayansingh MJ, Kariri T, Liang B, Ball TB, Ngugi EN, Plummer F, Luo M. 2013. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani sex worker cohort. Tissue Antigens 81:93-107. http://dx.doi.org/10.1111/tan.12051.
49. Itescu S, Mathur-Wagh U, Skovron ML, Brancato LJ, Marmor M, Zeleniuch-Jacquotte A, Winchester R. 1992. HLA-B35 is associated with accelerated progression to AIDS. J Acquir Immune Defic Syndr 5:37-45.
50. Sahmoud T, Laurian Y, Gazengel C, Sultan Y, Gautreau C, Costagliola D. 1993. Progression to AIDS in French haemophiliacs: association with HLA-B35. AIDS 7:497-500. http://dx.doi.org/10.1097/00002030-199304000-00007.
51. Tomiyama H, Miwa K, Shiga H, Moore YI, Oka S, Iwamoto A, Kaneko Y, Takiguchi M. 1997. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. J Immunol 158:5026-5034.
52. Scorza Smeraldi R, Fabio G, Lazzarin A, Eisera N, Uberti Foppa C, Moroni M, Zanussi C. 1988. HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts. Hum Immunol 22:73-79. http://dx.doi.org/10.1016/0198-8859(88)90038-9.
53. Scorza Smeraldi R, Lazzarin A, Moroni M, Fabio G, Eisera N, Zanussi C. 1986. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human immunodeficiency virus infection. Lancet 22:1187-1189.
54. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. 1999. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748-1752. http://dx.doi.org/10.1126/science.283.5408.1748.
55. Gao X, Bashirova A, Iversen AKN, Phair J, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Altfeld M, O'Brien SJ, Carrington M. 2005. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 11:1290-1292. http://dx.doi.org/10.1038/nm1333.
56. McKenzie LM, Pecon-Slattery J, Carrington M, O'Brien SJ. 1999. Taxonomic hierarchy of HLA class I allele sequences. Genes Immun 1:120-129. http://dx.doi.org/10.1038/sj.gene.6363648.
57. Hayashi H, Ooba T, Nakayama S, Sekimata M, Kano K, Takiguchi M. 1990. Allospecificities between HLA-Bw53 and HLA-B35 are generated by substitution of the residues associated with HLA-Bw4/Bw6 public epitopes. Immunogenetics 32:195-199. http://dx.doi.org/10.1007/BF02114973.
58. Mothe B, Llano A, Ibarrondo J, Zamarreño J, Schiaulini M, Miranda C, Ruiz-Riol M, Berger CT, Herrero MJ, Palou E, Plana M, Rolland M, Khatri A, Heckerman D, Pereyra F, Walker BD, Weiner D, Paredes R, Clotet B, Felber BK, Pavlakis GN, Mullins JI, Brander C. 2012. CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS One 7:e29717. http://dx.doi.org/10.1371/journal.pone.0029717.
59. Leslie A, Matthews PC, Listgarten J, Carlson JM, Kadie C, Ndung'u T, Brander C, Coovadia H, Walker BD, Heckerman D, Goulder PJR. 2010. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 84:9879-9888. http://dx.doi.org/10.1128/JVI.00320-10.
60. Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, Prentice HA, Yue L, Vishwanathan SA, Kilembe W, Goepfert P, Price MA, Gilmour J, Mulenga J, Farmer P, Derdeyn CA, Tang JJ, Heckerman D, Kaslow RA, Allen SA, Hunter E. 2012. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS Pathog 8:e1003041. http://dx.doi.org/10.1371/journal.ppat.1003041.
61. Fraser C, Hollingsworth TD. 2010. Interpretation of correlations in setpoint viral load in transmitting couples. AIDS 24:2596-2597. http://dx.doi.org/10.1097/QAD.0b013e32833e7a64.
62. Fraser C, Lythgoe K, Leventhal GE, Shirreff G, Hollingsworth TD, Alizon S, Bonhoeffer S. 2014. Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Science 343:1243727-1243727. http://dx.doi.org/10.1126/science.1243727.
63. Ammaranond P, van Bockel DJ, Petoumenos K, McMurchie M, Finlayson R, Middleton MG, Davenport MP, Venturi V, Suzuki K, Gelgor L, Kaldor JM, Cooper DA, Kelleher AD. 2011. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome. J Immunol 186:479-488. http://dx.doi.org/10.4049/jimmunol.0903227.
64. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, Rowland-Jones S. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3:212-217. http://dx.doi.org/10.1038/nm0297-212.
65. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR, McMichael AJ. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453-459. http://dx.doi.org/10.1038/354453a0.
66. Kelleher A, D, Long C, Holmes EC, Allen RL, Wilson J, Conlon C, Workman C, Shaunak S, Olson K, Goulder PJ, Brander C, Ogg G, Sullivan JS, Dyer W, Jones I, McMichael A, Rowland-Jones S, Phillips RE. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 193:375-386. http://dx.doi.org/10.1084/jem.193.3.375.
67. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, Nguyen T, Allen R, Trocha A, Altfeld M, He S, Bunce M, Funkhouser R, Pelton SI, Burchett SK, McIntosh K, Korber BT, Walker BD. 2001. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412:334-338. http://dx.doi.org/10.1038/35085576.